Comparative effectiveness of adjuvant chemoradiotherapy after gastrectomy among older patients with gastric adenocarcinoma: a SEER–Medicare study

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Gastric Cancer

• Publication date

  2017-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10120-017-0693-xPMID 28205057PMCID PMC5557693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gastric cancer adjuvant therapy.

  2016cited by this paper
• A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: First results from the CRITICS study.

  2016cited by this paper
• LBA-02A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: first results from the CRITICS study

  2016cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Does adjuvant radiotherapy benefit patients with diffuse‐type gastric cancer? Results from the Surveillance, Epidemiology, and End Results database

  2014cited by this paper
• Trends in the use of evidence‐based therapy for resectable gastric cancer

  2014cited by this paper
• Adjuvant treatment for gastric cancer: chemotherapy versus radiation.

  2013cited by this paper
• Gastric Cancer, Version 2.2013

  2013cited by this paper
• Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.

  2013cited by this paper
• Benefit of Adjuvant Chemoradiotherapy for Gastric Adenocarcinoma: A SEER Population Analysis.

  2013cited by this paper
• Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy

  2012cited by this paper
• Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.

  2012cited by this paper
• Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America

  2012cited by this paper
• Adjuvant Radiation Therapy Increases Overall Survival in Node-Positive Gastric Cancer Patients With Aggressive Surgical Resection and Lymph Node Dissection: A SEER Database Analysis

  2012cited by this paper
• Adjuvant therapy for elderly patients with resected gastric adenocarcinoma

  2012cited by this paper
• Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.

  2012cited by this paper
• Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.

  2011cited by this paper
• Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2010cited by this paper
• Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.

  2010cited by this paper
• Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival.

  2010cited by this paper
• Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies

  2010cited by this paper
• Stomach Carcinoma Incidence Patterns in the United States by Histologic Type and Anatomic Site

  2009cited by this paper
• Stage-Specific Effect of Adjuvant Therapy Following Gastric Cancer Resection: a Population-based Analysis of 4,041 Patients

  2008cited by this paper
• Estimating treatment effects using observational data.

  2007cited by this paper
• Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

  2006cited by this paper
• Recent advances in multimodal treatment for gastric cancer: a review

  2005cited by this paper
• Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type.

  2004cited by this paper
• Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study

  2004cited by this paper
• AJCC Cancer Staging Manual. 6th ed

  2002cited by this paper
• Use of SEER-Medicare Data for Measuring Cancer Surgery

  2002cited by this paper
• Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population

  2002cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

  2001cited by this paper
• Marginal Structural Models and Causal Inference in Epidemiology

  2000cited by this paper
• Development of a comorbidity index using physician claims data.

  2000cited by this paper
• Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.

  1999cited by this paper
• Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

  1998cited by this paper
• Estimating Causal Effects from Large Data Sets Using Propensity Scores

  1997cited by this paper
• Health Status of Medicare Enrollees in HMOs and Fee-for-Service in 1994

  1996cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

  1993cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• Reducing Bias in Observational Studies Using Subclassification on the Propensity Score

  1984cited by this paper
• The central role of the propensity score in observational studies for causal effects

  1983cited by this paper
• Analysis of survival by tumor response.

  1983cited by this paper
• THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

  1965cited by this paper

• Survival benefit of perioperative chemoradiotherapy in patients with resectable primary gastric adenosquamous carcinoma: a population-based cohort study

  2025cites this paper
• Understanding the association between clinical staging accuracy, treatment response, and survival among gastric cancer patients through Bayesian analysis

  2022cites this paper
• Estimating treatment effect on medical cost and examining medical cost trajectory using splines and change point techniques.

  2022cites this paper
• Decision-making of adjuvant therapy in pT1N1M0 gastric cancer: Should radiotherapy be added to chemotherapy? A propensity score-matched analysis

  2021cites this paper
• Treatment approach, hospital practice patterns, and receipt of multimodality therapy as measures of quality for locally advanced gastric cancer

  2021influential citation
• The Impact of Intervention on Survival of Elderly Patients with Gastric Cancer at IV Stage: A SEER Population-Based Study.

  2020cites this paper
• Estimates of Overall Survival in Patients With Cancer Receiving Different Treatment Regimens

  2020cites this paper
• Geriatric oncology health services research: Cancer and Aging Research Group Infrastructure Core.

  2020cites this paper
• Patterns of recurrence after curative D2 resection for gastric cancer: Implications for postoperative radiotherapy

  2020cites this paper
• Evaluation of comparative effectiveness research: a practical tool.

  2018cites this paper
• The appropriate treatment for elderly gastric cancer patients

  2017cites this paper